Qtrilmet approved in EU to treat type-2 diabetes

This article was originally published here

The approval is based on data from five Phase III trials which evaluated combinations of Forxiga (dapagliflozin) and Onglyza (saxagliptin) on a background of metformin in patients with

The post Qtrilmet approved in EU to treat type-2 diabetes appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply